» Articles » PMID: 9122853

[Value of Radiotherapy in Disseminated High-grade Non-Hodgkin's Lymphoma]

Overview
Specialties Oncology
Radiology
Date 1997 Mar 1
PMID 9122853
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiotherapy is part of the treatment protocols in localized low-grade lymphomas as well as localized high-grade lymphomas adjunct to polychemotherapy. Integration of radiotherapy into the treatment of disseminated high-grade lymphomas is controversial.

Patients And Method: The current literature and our own experience with radiotherapy as part of the treatment of disseminated high-grade lymphomas will be discussed.

Results: Retrospective analysis of large clinical trials suggest the value of radiotherapy in the treatment of disseminated high-grade lymphomas. Relapse occurs more frequently in non-irradiated regions than in fields of prior radiotherapy. Integration of radiotherapy into treatment protocols seems to be beneficial in patients with bulky disease. A dose/response relationship has been described. The few randomized trials, however, could not clearly demonstrate an advantage of radiotherapy adjuvant to chemotherapy in disseminated lymphomas. A possible advantage can be seen in patients who did not receive more than 4 cycles of polychemotherapy.

Conclusion: Although the value of radiotherapy adjunct to polychemotherapy in disseminated high-grade lymphomas has not been proven in randomized studies retrospective analysis suggest an advantage. A large randomized study should clarify the role of radiotherapy.

References
1.
Engelhard M, Meusers P, Brittinger G, Brack N, Dornoff W, Enne W . Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy. Ann Oncol. 1991; 2 Suppl 2:177-80. DOI: 10.1007/978-1-4899-7305-4_28. View

2.
Fisher R, Gaynor E, Dahlberg S, Oken M, Grogan T, Mize E . Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993; 328(14):1002-6. DOI: 10.1056/NEJM199304083281404. View

3.
Shipp M, Klatt M, Yeap B, Jochelson M, Mauch P, Rosenthal D . Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. J Clin Oncol. 1989; 7(5):613-8. DOI: 10.1200/JCO.1989.7.5.613. View

4.
Longo D, Glatstein E, Duffey P, Ihde D, Hubbard S, Fisher R . Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol. 1989; 7(9):1295-302. DOI: 10.1200/JCO.1989.7.9.1295. View

5.
Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N . LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol. 1989; 7(8):1018-26. DOI: 10.1200/JCO.1989.7.8.1018. View